http://www.unboundmedicine.com/medline/ebm/research/abacavirUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/18684101/full_citation/The_HCP5_Single_Nucleotide_Polymorphism:_A_Simple_Screening_Tool_for_Prediction_of_Hypersensitivity_Reaction_to_Abacavir_Colombo S, Rauch A, Rotger M, et al. 
The HCP5 Single-Nucleotide Polymorphism: A Simple Screening Tool for Prediction of Hypersensitivity Reaction to Abacavir. [JOURNAL ARTICLE]
J Infect Dis 2008 Sep 15; 198(6):864-867.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/18677028/full_citation/Antiretroviral_treatment_of_adult_HIV_infection:_2008_recommendations_of_the_International_AIDS_Society_USA_panel_Hammer SM, Eron JJ, Reiss P, et al. 
Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. [Consensus Development Conference, Journal Article, Practice Guideline, Research Support, Non-U.S. Gov't]
JAMA 2008 Aug 6; 300(5):555-70.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/18673126/full_citation/Pharmacogenomics_of_antiretrovirals_Roca B 
Pharmacogenomics of antiretrovirals. [Journal Article]
Recent Patents Anti-Infect Drug Disc 2008 Jun; 3(2):132-5.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/18671476/full_citation/Zidovudine/lamivudine/abacavir_plus_tenofovir_in_HIV_infected_naive_patients:_a_96_week_prospective_one_arm_pilot_study_Ferrer E, Gatell JM, Sanchez P, et al. 
Zidovudine/lamivudine/abacavir plus tenofovir in HIV-infected naive patients: a 96-week prospective one-arm pilot study. [Journal Article, Research Support, Non-U.S. Gov't]
AIDS Res Hum Retroviruses 2008 Jul; 24(7):931-4.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/18670229/full_citation/First_large_multicenter_open_label_study_utilizing_HLA_B_5701_screening_for_abacavir_hypersensitivity_in_North_America_Young B, Squires K, Patel P, et al. 
First large, multicenter, open-label study utilizing HLA-B*5701 screening for abacavir hypersensitivity in North America. [Journal Article, Research Support, Non-U.S. Gov't]
AIDS 2008 Aug 20; 22(13):1673-5.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/18663041/full_citation/Efficacy_and_tolerability_of_a_fosamprenavir_ritonavir_based_versus_a_lopinavir_ritonavir_based_antiretroviral_treatment_in_82_therapy_nayive_patients_with_HIV_1_infection_Calza L, Manfredi R, Pocaterra D, et al. 
Efficacy and tolerability of a fosamprenavir-ritonavir-based versus a lopinavir-ritonavir-based antiretroviral treatment in 82 therapy-nayive patients with HIV-1 infection. [Journal Article]
Int J STD AIDS 2008 Aug; 19(8):541-4.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/18661643/full_citation/Anti_HIV_agents__Controversial_findings_on_abacavir_and_heart_attacks_Anti-HIV agents. Controversial findings on abacavir and heart attacks. [Newspaper Article]
TreatmentUpdate 2008 Mar; 20(2):1-5.
Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/18645663/full_citation/[Patterns_of_antiretroviral_drug_prescripcion_in_997_Colombian_patients_]Machado JE, Alzate JA 
[Patterns of antiretroviral drug prescripcion in 997 Colombian patients.] [English Abstract, Journal Article]
Biomedica 2008 Mar; 28(1):78-86.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/18642404/full_citation/FDA_notifications__Large_study_suggests_heart_attack_risk_from_use_of_abacavir_or_didanosine_FDA notifications. Large study suggests heart attack risk from use of abacavir or didanosine. [Newspaper Article]
AIDS Alert 2008 May; 23(5):58-9.
Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/18631255/full_citation/Switching_from_twice_daily_abacavir_and_lamivudine_to_the_once_daily_fixed_dose_combination_tablet_of_abacavir_and_lamivudine_improves_patient_adherence_and_satisfaction_with_therapy_Maitland D, Jackson A, Osorio J, et al. 
Switching from twice-daily abacavir and lamivudine to the once-daily fixed-dose combination tablet of abacavir and lamivudine improves patient adherence and satisfaction with therapy. [JOURNAL ARTICLE]
HIV Med 2008 Jul 2.
Abstract | Full Citation | Find Related Articles